Compounds such as 4-butyl-polyhydroxybenzophenone have been shown to enhance mitochondrial biogenesis and protect against MASLD-related liver injury via the SIRT1-PGC-1α pathway (Song et al., 2023). Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.